# Carbidopa and levodopa

NDC: 71610-664
Generic name: Carbidopa and levodopa
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220315

FDA application: ANDA074260

## Active ingredients

- CARBIDOPA: 25 mg/1
- LEVODOPA: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-664"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-664
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64254508-dbe7-4512-902d-f4a6ef2bfdf8